Lead Identification & Optimization topic: Early immunogenicity risk assessment and functional testing of biotherapeutics
18 Nov 2024
Formats & Scaffolds
)
- In silico and in vitro immunogenicity assessment as a de-risking strategy
- Approaches to mitigate the unwanted immunogenicity of therapeutic proteins
- Designing low immunogenic antibodies
- In vitro Functional testing of lead candidates
